Background: Angiogenesis is essential for tumor growth and metastasis and t
he vascular density is known as an independent prognostic factor in several
tumor entities. The aim of this paper was to examine the vascular density
and to test its prognostic relevance in colorectal cancer.
Methods: The population included 146 patient who were treated surgically fo
r cure. Sections of these tumors were immunostained with the monoclonal ant
ibody JC70, an endothelial cell marker, and with an monoclonal antibody dir
ected against bFGE Microvessel quantification was assessed with a light mic
roscope. All of the slides were scanned at a low magnification and individu
al microvessel counts were made on a X200 field in the area of the most den
se neovascularization.
Results: Vascular density was 75 +/- 27/visual field which was independent
of age, sex, pT and pN-category, occurrence of recurrence and overall survi
val. Only recurrence-free survival was significantly shorter in tumors with
higher density (> 70) than in tumors with lower density (< 70). The angiog
enetic factor bFGF was only expressed in 17.1% of all patients and independ
ent of tumor stage, differentiation and prognosis.
Conclusions: Our results confirm that the growth of a tumor is accompanied
by the onset of neovascularization. The immunostaining of tumor sections wi
th JC70 is an objective and reproducible method to quantify the vascular de
nsity in colorectal cancer. We could show that the quantification of angiog
enesis is of little importance in clinical riskstratification for patients
with colorectal cancer.